Ambani Orgochem (AMBANIORGO)

Score breakdown: P/E: 0/3 · ROCE: 0/2 · Growth: 2/2 · Dividend: 0/1

Key Financials

Strengths

• Sales growth of 34.9% shows strong top-line momentum.
• Profit growth of 110.67%, albeit off a low base, demonstrates an improving earnings trend.
• Piotroski F-Score of 7/9 suggests decent operational fundamentals.
• Promoter holding of 61.25% aligns management with minority shareholders.

Concerns

• Latest quarter net profit of ₹0 Cr on ₹111 Cr sales indicates margin compression or one-offs.
• P/E of 166.17 with tiny trailing earnings implies excessive valuation.
• ROCE of 7.12% is low for specialty chemicals and suggests limited moat.
• No dividend yield, so investors depend entirely on uncertain capital gains.

AI Analysis

Ambani Orgochem is a puzzle that fails Graham's first test: clarity. The headline numbers look promising—34.9% sales growth and 110.67% profit growth—but when I look at the latest quarter, I see ₹111 Cr of sales and ₹0 Cr of net profit. A business can sell a great deal and still earn nothing; that is not business success, it is activity. At a P/E of 166.17, the market is paying an enormous premium for a microscopic profit stream. The trailing earnings are tiny, and with no dividend yield, the return to shareholders rests entirely on hope. ROCE at 7.12% is far below what I require for a specialty chemical company with a moat; high returns on capital are the true measure of a durable franchise. The Piotroski F-Score of 7/9 is a positive signal, and promoter holding of 61.25% aligns owners with public shareholders, but neither justifies a PEG of 2.28. I also cannot assess the balance sheet because book value and debt/equity are not available. Graham would insist on a margin of safety; at ₹132, near the top of the 52-week range, I don't see one. The latest quarter's zero profit makes the P/E unreliable. This looks more like a turnaround-or-growth story that needs proof. I need to see sales growth convert into net profit, ROCE improve materially, and management provide full balance-sheet transparency before I can consider owning it.

Data from BSE/NSE filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer